Australia's Oncosil gains on positive results for cancer treatment device

Oncosil Medical

24/12/2021 02:57

** Shares of the medical device developer  OSL.AX  soar as much
as 25.6% to A$0.049, on track for biggest pct jump since Sept
2020
    ** Co says an international, multi-centre clinical study
shows encouraging safety and efficacy results for its OncoSil
device being developed to advance radiation for cancer patients
 urn:newsml:reuters.com:*:nASX27RjLS
    ** OSL says results showed OncoSil device had an acceptable
safety profile when added to standard-of-care chemotherapy used
for treating patients with advanced pancreatic cancer
    ** Adds that the full paper of the clinical study has been
published in the European Society for Medical Oncology's journal
    ** Shares hit highest levels since Nov 22
    ** More than 5.2 mln shares change hands vs 30-day average
volume of ~1.1 mln shares  
    ** Stock has fallen 67.5% this year, as of last close


 (Reporting by Roushni Nair in Bengluru)
 ((Roushni.Nair@thomsonreuters.com;))